Literature DB >> 23891390

Cultural adaptation and validation of the Pelvic Floor Distress Inventory short form (PFDI-20) and Pelvic Floor Impact Questionnaire short form (PFIQ-7) Spanish versions.

Beatriz Sánchez-Sánchez1, María Torres-Lacomba, María José Yuste-Sánchez, Beatriz Navarro-Brazález, Soraya Pacheco-da-Costa, Carlos Gutiérrez-Ortega, Álvaro Zapico-Goñi.   

Abstract

OBJECTIVE: To develop a linguistically adapted and psychometrically validated Spanish version of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire Short Forms (PFDI-20 and PFIQ-7) to assess symptoms and quality of life in Spanish women with pelvic floor disorders. STUDY
DESIGN: Cross-cultural linguistic adaptation was performed following the translation-backtranslation method in 30 native Spanish-speaking women with pelvic floor disorders to obtain PFDI-20 and PFIQ-7 Spanish versions. The psychometric properties were evaluated in 114 women with pelvic floor disorders. We calculated the reliability with the intraclass correlation coefficient and Cronbach's alpha coefficient, the validity with Spearman coefficient, the feasibility with the response rate and the filling time, and the ceiling and floor effects.
RESULTS: Spanish versions of the PFDI-20 and PFIQ-7 achieved good semantic, conceptual, idiomatic and content equivalence. Concerning the psychometric validation, internal consistency was high with Cronbach's alpha coefficient of 0.837 (p<0.001) for PFDI-20 and 0.967 (p<0.001) for PFIQ-7. The test-retest reliability was 0.644 (p<0.001) for the PFDI-20 and 0.786 (p<0.001) for the PFIQ-7. Good construct validity was found with questionnaires: SF-12, EPIQ and ICIQ-SF. The average administration time was 10.1 (5.8)min for the PFDI-20, and 7.5 (4.7)min for the PFIQ-7. A ceiling effect was detected in the PFIQ-7 (25.4%).
CONCLUSIONS: The PFDI-20 and PFIQ-7 Spanish versions showed semantic, conceptual, idiomatic and content equivalence with the original versions. Both instruments are reliable, valid and feasible to evaluate symptoms and quality of life in Spanish women with pelvic floor disorders.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Pelvic floor disorders; Quality of life questionnaire; Spanish validation

Mesh:

Year:  2013        PMID: 23891390     DOI: 10.1016/j.ejogrb.2013.07.006

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  13 in total

1.  Spanish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA-Revised (PISQ-IR): Transcultural validation.

Authors:  Montserrat Mestre; Judith Lleberia; Josep Pubill; Montserrat Espuña-Pons
Journal:  Int Urogynecol J       Date:  2017-04-08       Impact factor: 2.894

2.  Reducing postoperative catheterisation after anterior colporrhaphy from 48 to 24 h: a randomised controlled trial.

Authors:  Sergi Fernandez-Gonzalez; Eva Martinez Franco; Rubén Martínez-Cumplido; Cristina Molinet Coll; Funesanta Ojeda González; Maria Dolores Gómez Roig; Lluís Amat Tardiu
Journal:  Int Urogynecol J       Date:  2018-11-27       Impact factor: 2.894

3.  Validation and cultural translation for Brazilian Portuguese version of the Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20).

Authors:  Mariana Alves Fernandes Arouca; Thaiana Bezerra Duarte; Daniela Alves Malzone Lott; Pedro Sérgio Magnani; Antonio Alberto Nogueira; Júlio César Rosa-E-Silva; Luiz Gustavo Oliveira Brito
Journal:  Int Urogynecol J       Date:  2016-01-19       Impact factor: 2.894

4.  Reliability and validity of a Turkish version of the Global Pelvic Floor Bother Questionnaire.

Authors:  Hanife Doğan; Nuriye Özengin; Yeşim Bakar; Bülent Duran
Journal:  Int Urogynecol J       Date:  2016-04-01       Impact factor: 2.894

5.  Validation of the short forms of the Pelvic Floor Distress Inventory (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ-7), and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) in Finnish.

Authors:  Nina Kristiina Mattsson; Kari Nieminen; Anna-Mari Heikkinen; Jyrki Jalkanen; Sari Koivurova; Marja-Liisa Eloranta; Pia Suvitie; Anna-Maija Tolppanen
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

6.  The Female Sexual Function Index: Transculturally Adaptation and Psychometric Validation in Spanish Women.

Authors:  Beatriz Sánchez-Sánchez; Beatriz Navarro-Brazález; Beatriz Arranz-Martín; Óscar Sánchez-Méndez; Irene de la Rosa-Díaz; María Torres-Lacomba
Journal:  Int J Environ Res Public Health       Date:  2020-02-05       Impact factor: 3.390

7.  Effectiveness of Hypopressive Exercises in Women with Pelvic Floor Dysfunction: A Randomised Controlled Trial.

Authors:  Beatriz Navarro-Brazález; Virginia Prieto-Gómez; David Prieto-Merino; Beatriz Sánchez-Sánchez; Linda McLean; María Torres-Lacomba
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

8.  Cross-Cultural Adaptation and Validation of the Oslo Sports Trauma Research Center Questionnaires on Overuse Injury and Health Problems (2nd Version) in Spanish Youth Sports.

Authors:  Javier Bailón-Cerezo; Benjamin Clarsen; Beatriz Sánchez-Sánchez; María Torres-Lacomba
Journal:  Orthop J Sports Med       Date:  2020-12-11

9.  Postural Sensorimotor Control on Anorectal Pressures and Pelvic Floor Muscle Tone and Strength: Effects of a Single 5P® LOGSURF Session. A Cross-Sectional Preliminary Study.

Authors:  Laura Fuentes-Aparicio; Beatriz Arranz-Martín; Beatriz Navarro-Brazález; Javier Bailón-Cerezo; Beatriz Sánchez-Sánchez; María Torres-Lacomba
Journal:  Int J Environ Res Public Health       Date:  2021-04-02       Impact factor: 3.390

10.  Bladder Base Displacement during Abdominal Muscles Contraction and Functional Activities in Primiparous Women Assessed by Transabdominal Ultrasound: A Descriptive Study.

Authors:  Beatriz Arranz-Martín; Patricia García-Gallego; Helena Romay-Barrero; Beatriz Navarro-Brazález; Carlos Martínez-Torres; María Torres-Lacomba
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.